AC Immune (ACIU) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $135.6 million.
- AC Immune's Cash & Current Investments rose 27148.21% to $135.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.6 million, marking a year-over-year increase of 27148.21%. This contributed to the annual value of $188.9 million for FY2024, which is 9931.97% down from last year.
- As of Q3 2025, AC Immune's Cash & Current Investments stood at $135.6 million, which was up 27148.21% from $153.6 million recorded in Q2 2025.
- In the past 5 years, AC Immune's Cash & Current Investments registered a high of $125.9 billion during Q4 2021, and its lowest value of -$79.1 million during Q3 2024.
- Moreover, its 5-year median value for Cash & Current Investments was $127.2 million (2022), whereas its average is $12.0 billion.
- Per our database at Business Quant, AC Immune's Cash & Current Investments soared by 5951971.46% in 2021 and then tumbled by 19321.28% in 2024.
- AC Immune's Cash & Current Investments (Quarter) stood at $125.9 billion in 2021, then plummeted by 99.9% to $127.2 million in 2022, then soared by 21723.36% to $27.8 billion in 2023, then plummeted by 99.32% to $188.9 million in 2024, then fell by 28.22% to $135.6 million in 2025.
- Its Cash & Current Investments stands at $135.6 million for Q3 2025, versus $153.6 million for Q2 2025 and $162.0 million for Q1 2025.